Discover Weakness Deemed Unwarranted and 4 Stock Analyses to Know Now
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX): Current Price: $8.10
The company’s price target has been increased to $15 by Brean Capital due to positive Ph III Zerenex data. The stock has a Buy rating.
Discover Financial Services (NYSE:DFS): Current Price: $38.09
According to Buckingham, recent weakness in Discover is on no new information and is unwarranted. Buckingham claims it would use weakness to add to positions and it keeps its Buy rating and $47 price target on the stock.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.
Walgreen Co. (NYSE:WAG): Current Price: $39.89
Barrington has decided to keep an Outperform rating on Walgreen shares.
Symantec Corporation (NASDAQ:SYMC): Current Price: $21.81
Symantec announced a new strategic plan which has influenced Argus to believe that the company is well-positioned. The firm keeps a Buy rating but raised its target to $27 from $24 on the stock.
Transocean Ltd. (NYSE:RIG): Current Price: $57.83
Carl Icahn revealed that he obtained an aggregate 5.61 percent of Transocean’s shares and pushed the company to pay a $4 per share dividend, causing Wells Fargo to believe that the company could pay the dividend. The firm thinks that shareholders will back Icahn’s proposal and it keeps its Outperform rating on the stock.